Background-Many studies have shown that coronary flow reserve is reduc
ed in patients with chest pain and angiographically normal coronary ar
teries. The methods used to assess coronary blood flow have varied, bu
t in nearly all reports dipyridamole has been used to bring about vaso
dilatation. This study was designed to assess whether the apparent imp
airment of coronary flow reserve seen with dipyridamole could be repro
duced with either papaverine or adenosine, which induce maximum corona
ry blood flow by different mechanisms. Methods-25 patients with chest
pain and angiographically normal coronary arteries were studied with a
n intracoronary Doppler flow probe and quantitative angiography to det
ermine epicardial coronary artery area, coronary blood flow velocity,
coronary flow reserve, and coronary vascular resistance index (CVRI, t
he ratio of resistance after intervention to basal resistance). All pa
tients received papaverine 8 mg. Eight patients with positive exercise
tests received intracoronary papaverine (8 and 10 mg), intracoronary
adenosine (6, 20, 60 mu g), and high-dose intravenous dipyridamole (0
84 mg/kg). Results-The velocity ratio (peak after intervention: baseli
ne) (mean (SEM)) after 8 mg papaverine was 3.3 (0.2) (n = 25) and the
coronary flow reserve was 4.1 (0.3) (n = 25). There were no difference
s between patients with a positive (n = 16) or negative (n = 9) exerci
se test. In eight patients coronary flow reserve was measured after in
creasing doses of papaverine, adenosine, and dipyridamole. Coronary fl
ow reserve was 4.5 (0.3) with papaverine, 4.8 (0.3) with adenosine, an
d 3.5 (0.4) with dipyridamole (p= 0.08 nu paverine and adenosine). CVR
I was 0.22 (0.01) with papaverine, 0.21 (0.02) with adenosine, and 0.2
9 (0.03) with dipyridamole (p < 0 05 nu papaverine, p = 0 09 nu adenos
ine). Conclusions-These results indicate that measurement of coronary
flow reserve and CVRI in patients with chest pain and normal coronary
arteries depends on the pharmacological stimulus. Normal values were o
btained with papaverine in all patients, irrespective of the exercise
test response. In patients with a positive exercise test significantly
lower values were obtained with dipyridamole than with papaverine, or
adenosine. The reported impairment of coronary flow reserve in patien
ts with angina and normal coronary arteries may reflect the variabilit
y in response to different pharmacological agents. The mechanism under
lying this variability is unknown, but may involve an abnormality of a
denosine metabolism in the myocardium.